Copeland Capital Management’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-121,075
Closed -$4.59M 166
2015
Q4
$4.59M Sell
121,075
-1,151
-0.9% -$42.4K 0.26% 103
2015
Q3
$5.04M Sell
122,226
-204,478
-63% -$8.78M 0.31% 98
2015
Q2
$15.4M Buy
326,704
+133,467
+69% +$7.22M 0.79% 58
2015
Q1
$11.6M Sell
193,237
-8,643
-4% -$440K 0.77% 60
2014
Q4
$8.82M Buy
201,880
+28,846
+17% +$1.27M 0.64% 58
2014
Q3
$7.79M Buy
173,034
+1,098
+0.6% +$58.4K 0.79% 52
2014
Q2
$12.7M Buy
171,936
+55,111
+47% +$4.34M 1.42% 46
2014
Q1
$9.68M Buy
116,825
+68,063
+140% +$5.98M 1.18% 51
2013
Q4
$6.74M Buy
48,762
+44,704
+1,102% +$5.26M 0.88% 50
2013
Q3
$389K Sell
4,058
-366
-8% -$31.1K 0.06% 83
2013
Q2
$270K Buy
+4,424
New +$246K 0.05% 78

Other funds holding NUS

Copeland Capital Management's NUS Position: Q1 2016 in Review

Copeland Capital Management sold out of Nu Skin (NUS) in Q1 2016, closing a stake of 121,075 shares — an estimated $4.59M sold.

Copeland Capital Management first reported a position in NUS in Q2 2013 and held it in 11 quarters. The position peaked at $15.4M in Q2 2015. 197 funds tracked by Wall St. Rank hold NUS as of Q1 2016.

  • Copeland Capital Management reported no remaining Nu Skin position as of Q1 2016 after selling out during the quarter.
  • Copeland Capital Management sold 121,075 Nu Skin shares in Q1 2016, an estimated $4.59M.
  • Copeland Capital Management first reported a position in Nu Skin in Q2 2013 and held it in 11 quarters.
  • Copeland Capital Management's Nu Skin position peaked at $15.4M in Q2 2015.
  • 197 funds tracked by Wall St. Rank held Nu Skin as of Q1 2016.

Based on Copeland Capital Management's 13F filing for Q1 2016, filed 9 May 2016.